Higher and broader immunogenicity following MF59-adjuvanted influenza vaccination (Fluad®) in at-risk adults (18-60 years of age) a randomized, controlled, observer-blind study
2009
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI